Analyst firms · Citigroup · DGX

Citigroup DGX price target and rating history

Quest Diagnostics Incorporated (DGX) · Health Care

Citigroup rates Quest Diagnostics Incorporated (DGX) Neutral with a $185 price target, as of its latest action on Mar 4, 2025. It has published 5 rating actions on DGX since April 2022, including 2 upgrades and 3 downgrades.

Current rating
Neutral
Price target
$185
Median target, all firms
Too few
Actions on DGX
5

Citigroup price target on DGX

$185$155$1252023202420252026
Citigroup price target on DGX, each point a stated target, April 2022 to March 2025.

Every Citigroup rating on DGX

Questions about Citigroup and DGX

What is Citigroup's price target for DGX?
Citigroup's latest stated price target for Quest Diagnostics Incorporated (DGX) is $185, from its action on Mar 4, 2025.
What is Citigroup's rating on DGX?
Citigroup rates DGX Neutral, a neutral rating, as of Mar 4, 2025.
When did Citigroup last change its view on DGX?
On Mar 4, 2025, Citigroup downgrades to Neutral from Buy, price target $185.

More DGX rating histories

All Citigroup ratingsDGX news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.